India, May 29 -- The share of this company, which is an Indian, Mumbai-based manufacturer of Active Pharmaceutical Ingredients (APIs) and pharmaceutical intermediates, gained investor traction after reporting strong Q4 numbers

With a market capitalization of Rs 7,796 crore, Supriya Lifescience Ltd's shares made a day high of Rs 968.70 per share, hitting the upper circuit of 20 percent from its previous day's close price of Rs 807.25 per share. The share of this company gave a return of 29 percent over the last year.

Result overview QoQ View: The revenue from operations grew by 34.0 percent to Rs 276.53 crore in Q4 FY26 from Rs 206.44 crore in Q3 FY26, and EBITDA grew by 35.4 percent to Rs 97.62 crore in Q4 FY26 from Rs 72.08 crore in Q3...